FORCEFIELD THERAPEUTICS

Updated 10 days ago
Private Limited Company
  • Active - 12543677 (CH)
  • Age: 4 years
  • ID: 49278456/17
Rolling Stock Yard 188 York Way London N7 9AS
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 72110 - Research and experimental development on biotechnology
Our aim is to revolutionise treatment following acute myocardial infarction and to prevent the cascade of events that may lead to subsequent heart failure. Professor Giacca's ground-breaking research is the first step in achieving this goal."... Forcefield's leadership team has a track record of success in delivering novel discovery biology in cardiovascular disease, biopharmaceutical development and commercialisation, and building successful companies... Forcefield's unparalleled approach can protect heart cells, minimising the impact of a heart attack (myocardial infarction or MI) and preventing the cascade of events that may lead to subsequent heart failure.
Also known as: Forcefield, PURESPRING THERAPEUTICS LIMITED
Previous names: SYNCONA COLLABORATION (S) LIMITED
Registration numbers: 12543677 (CH)
Primary location: London United Kingdom
Associated domains: purespringtx.com
  • 0
  • 0
Interest Score
1
HIT Score
0.82
CEO
John Tsai
COO
Dan Gliddon
General
co..@forcefieldtx.com, co..@forcefieldtx.com

UK Company Data

Company number
12543677		 Account category
SMALL		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2024-09-30		 Accounts last made up date
2022-12-31		 Returns next due date
2021-04-29		 Returns last made up date
N/A
Num. mort. charges
0		 Num. mort. outstanding
0		 Num. mort. part. satisfied
0		 Num. mort. satisfied
0
Num. gen. partners
0		 Num. lim. partners
0
Domain
forcefieldtx.com
Actual
forcefieldtx.com
IP
92.205.26.25
Status
OK
Category
Company
0 comments Add a comment